Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Molecular Staging of Lung Cancer Stages I and IIp: Generation and Initial Analysis of a Clinical and Molecular Knowledge Database

NCT03286036 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT03286036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03286036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Molecular Staging of Lung Cancer Stages I and IIp: Generation and Initial Analysis of a Clinical and Molecular Knowledge Database
Lead sponsor
Corporacion Parc Tauli
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2013
Completion date
December 31, 2020
Enrollment
200 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer